Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 67

1.

Vanilloid-like agents inhibit aggregation of human platelets.

Almaghrabi SY, Geraghty DP, Ahuja KD, Adams MJ.

Thromb Res. 2014 Aug;134(2):412-7. doi: 10.1016/j.thromres.2014.05.038. Epub 2014 Jun 6.

PMID:
24953906
2.

The impact of pre-intervention rate of kidney function change on the assessment of CKD progression.

Fassett RG, Geraghty DP, Coombes JS.

J Nephrol. 2014 Oct;27(5):515-9. doi: 10.1007/s40620-014-0058-z. Epub 2014 Feb 7.

PMID:
24504906
3.

Hypolipidaemic effect of crude extract from Carpobrotus rossii (pigface) in healthy rats.

Pirie AD, Davies NW, Ahuja KD, Adams MJ, Shing CM, Narkowicz C, Jacobson GA, Geraghty DP.

Food Chem Toxicol. 2014 Apr;66:134-9. doi: 10.1016/j.fct.2014.01.034. Epub 2014 Jan 27.

PMID:
24480043
4.

Effects of atorvastatin on biomarkers of inflammation in chronic kidney disease.

Fassett RG, Robertson IK, Ball MJ, Geraghty DP, Coombes JS.

Clin Nephrol. 2014 Feb;81(2):75-85. doi: 10.5414/CN108090.

PMID:
24321183
5.
6.

Relationship between antioxidant enzyme genotype and activity and kidney function: a case-control study.

Crawford A, Fassett RG, Coombes JS, Kunde DA, Ahuja KD, Robertson IK, Ball MJ, Geraghty DP.

Clin Nephrol. 2012 Aug;78(2):135-44.

PMID:
22790458
7.

Relationships between single nucleotide polymorphisms of antioxidant enzymes and disease.

Crawford A, Fassett RG, Geraghty DP, Kunde DA, Ball MJ, Robertson IK, Coombes JS.

Gene. 2012 Jun 15;501(2):89-103. doi: 10.1016/j.gene.2012.04.011. Epub 2012 Apr 14. Review.

PMID:
22525041
8.

Vascular function and mortality in haemodialysis patients: a pilot study.

Dalton BS, Fassett RG, Geraghty DP, De Ryke R, Coombes JS.

Arch Cardiovasc Dis. 2011 Oct;104(10):518-23. doi: 10.1016/j.acvd.2011.06.005. Epub 2011 Sep 29.

9.
10.

Effects of atorvastatin on NGAL and cystatin C in chronic kidney disease: a post hoc analysis of the LORD trial.

Fassett RG, Robertson IK, Ball MJ, Geraghty DP, Cardinal JW, Coombes JS.

Nephrol Dial Transplant. 2012 Jan;27(1):182-9. doi: 10.1093/ndt/gfr193. Epub 2011 May 4.

11.

Effects of systemic capsaicin treatment on TRPV1 and Tachykinin NK(1) receptor distribution and function in the nucleus of the solitary tract of the adult rat.

Geraghty DP, Mazzone SB, Carter C, Kunde DA.

Pharmacology. 2011;87(3-4):214-23. doi: 10.1159/000324530. Epub 2011 Mar 25.

PMID:
21430411
12.

TRPV1, NK1 receptor and substance P immunoreactivity and gene expression in the rat lumbosacral spinal cord and urinary bladder after systemic, low dose vanilloid administration.

Heng YJ, Saunders CI, Kunde DA, Geraghty DP.

Regul Pept. 2011 Apr 11;167(2-3):250-8. doi: 10.1016/j.regpep.2011.02.004. Epub 2011 Feb 15.

PMID:
21329730
13.

Glutathione peroxidase, superoxide dismutase and catalase genotypes and activities and the progression of chronic kidney disease.

Crawford A, Fassett RG, Coombes JS, Kunde DA, Ahuja KD, Robertson IK, Ball MJ, Geraghty DP.

Nephrol Dial Transplant. 2011 Sep;26(9):2806-13. doi: 10.1093/ndt/gfq828. Epub 2011 Feb 16.

14.

In vitro antioxidant, antiplatelet and anti-inflammatory activity of Carpobrotus rossii (pigface) extract.

Geraghty DP, Ahuja KD, Pittaway J, Shing C, Jacobson GA, Jager N, Jurković S, Narkowicz C, Saunders CI, Ball M, Pinkard A, Vennavaram RR, Adams MJ.

J Ethnopharmacol. 2011 Mar 8;134(1):97-103. doi: 10.1016/j.jep.2010.11.060. Epub 2010 Dec 3.

PMID:
21130860
15.

Effect of atorvastatin on kidney function in chronic kidney disease: a randomised double-blind placebo-controlled trial.

Fassett RG, Robertson IK, Ball MJ, Geraghty DP, Coombes JS.

Atherosclerosis. 2010 Nov;213(1):218-24. doi: 10.1016/j.atherosclerosis.2010.07.053. Epub 2010 Aug 11.

PMID:
20810109
16.

Effects of atorvastatin on arterial stiffness in chronic kidney disease: a randomised controlled trial.

Fassett RG, Robertson IK, Ball MJ, Geraghty DP, Sharman JE, Coombes JS.

J Atheroscler Thromb. 2010 Mar 31;17(3):235-41. Epub 2009 Dec 24.

17.

Up-regulation of TRPV1 in mononuclear cells of end-stage kidney disease patients increases susceptibility to N-arachidonoyl-dopamine (NADA)-induced cell death.

Saunders CI, Fassett RG, Geraghty DP.

Biochim Biophys Acta. 2009 Oct;1792(10):1019-26. doi: 10.1016/j.bbadis.2009.07.008. Epub 2009 Jul 18.

18.

Effect of capsaicin and dihydrocapsaicin on in vitro blood coagulation and platelet aggregation.

Adams MJ, Ahuja KD, Geraghty DP.

Thromb Res. 2009 Dec;124(6):721-3. doi: 10.1016/j.thromres.2009.05.001. Epub 2009 May 23. No abstract available.

PMID:
19476975
19.

Physical activity levels in patients with chronic kidney disease entering the LORD trial.

Fassett RG, Robertson IK, Geraghty DP, Ball MJ, Burton NW, Coombes JS.

Med Sci Sports Exerc. 2009 May;41(5):985-91. doi: 10.1249/MSS.0b013e3181940aef.

PMID:
19346990
20.

Comparison of markers of oxidative stress, inflammation and arterial stiffness between incident hemodialysis and peritoneal dialysis patients--an observational study.

Fassett RG, Driver R, Healy H, Ranganathan D, Ratanjee S, Robertson IK, Geraghty DP, Sharman JE, Coombes JS.

BMC Nephrol. 2009 Mar 12;10:8. doi: 10.1186/1471-2369-10-8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk